The nation’s only nonprofit singularly dedicated to novel research in lupus, we champion innovation and scientific risk-taking in the hunt for solutions to this complex and dangerous autoimmune disease.
Information
- Founded:
- 2000
Causes
Notes
3 of 54 notesSee All
- Human Genome Sciences and GlaxoSmithKline Announce Positive Results in Second of Two Phase 3 Trials of Benlysta™ in Lupus 9:49am Nov 2|1 Comment
- Benlysta™ trial results in an historic research breakthrough and victory for people with lupus 3:47am Nov 2|10 Comments
- Lupus Research Institute Earns A+ from American Institute of Philanthropy 11:27am Oct 30
Events
2 past eventsSee All
- The Shady Ladies® Luncheon and...
The Palm Beach International Equest...
Sunday, March 15 at 12:00am - ShopForLupus.org
www.ShopForLupus.org
Wednesday, December 12 at 4:00pm
Lupus Research Institute
Only lupus organization designated a “Top Rated Charity” by national charity watchdogOf the over 500 charities rated by the American Institute of Philanthropy (AIP) this year, the Lupus Research Institute (LRI) is the nation’s only lupus organization to meet the stringent standards for finan...
Lupus Research Institute It's time to get informed about lupus and the flu - especially the H1N1 virus. Check out this Q&A from the S.L.E. Lupus Foundation w/ Dr. Richard Furie.
Source: www.lupusny.org
We’ve been fielding a lot of calls about the flu this fall—and understandably so! Along with the seasonal flu, there's now the universal worry over the flu caused by the H1N1 virus. Often called the “swine” flu because it’s common in pigs, this virus first started getting humans sick in April 2009. ...
BENLYSTA (belimumab) 10 mg/kg plus standard of care met its primary efficacy endpoint by achieving a statistically significant improvement in patient response rate versus placebo plus standard of care at Week 52 in BLISS-76 Primary efficacy endpoint met in two pivotal Phase 3 trials, as...
Lupus Research Institute LRI president Margaret Dowd is quoted in this NY Times' story on Benlysta. Take a look!
Source: www.nytimes.com
Human Genome Sciences said early Monday that its experimental drug to treat lupus was effective in its second big clinical trial.
Second successful phase III trial points to the first new lupus treatment in over 50 yearsNew York, NY (November 2, 2009) -- The Lupus Research Institute (LRI) and its National Coalition of state and local lupus organizations congratulate Human Genome Sciences (HGS) and GlaxoSmithKline for...
Lupus Research Institute Benlysta™ trial results in an historic research breakthrough and victory for people with lupus!
Source: www.hgsi.com
Human Genome Sciences is an emerging pharmaceutical company with the mission to predict, prevent, detect, treat and cure disease.
Lupus Research Institute Stay tuned Monday for results from HGS's second Phase 3 clincal trial for Benlysta, a new treatment in development for SLE. Significant news for the lupus community!
HUMAN GENOME SCIENCES TO HOST NOVEMBER 2ND CONFERENCE CALL TO DISCUSS TOP-LINE RESULTS FROM SECOND P
Source: www.hgsi.com
Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it expects to have top-line 52-week results available on Monday, November 2nd, from BLISS-76, the second of two pivotal Phase 3 clinical trials of BENLYSTA™ (belimumab) in systemic lupus erythematosus (SLE).
PHILADELPHIA – For patients with systemic lupus erythematosus, depression further increases their already elevated risk for cardiovascular disease, researchers said here. ...
More Than a Dozen Different Genes May Play a Role in Causing LupusOct. 19, 2009 – At least a dozen or more genes may help explain what causes lupus, according to two new studies. ...
Human Genome Sciences and GlaxoSmithKline Report Details of First Positive Phase 3 Clinical Trial for LupusPhiladelphia, October 20, 2009—Drug company Human Genome Sciences (HGS) and GlaxoSmithKline (GSK) today reported details of the first of their two crucial Phase 3 trials of belimumab (...
Lupus Research Institute
HGS presents at ACR: BENLYSTA significantly reduced SLE disease activity,
disease flare rates and fatigue; significantly delayed time-to-first
SLE disease flare; reduced prednisone use and improved health-related
patient quality of life in the BLISS-52 study
HUMAN GENOME SCIENCES AND GLAXOSMITHKLINE ANNOUNCE FULL PRESENTATION AT ACR OF POSITIVE PHASE 3 STUD
Source: www.hgsi.com
Human Genome Sciences is an emerging pharmaceutical company with the mission to predict, prevent, detect, treat and cure disease.
Inspiration to Beatles’ ‘Lucy in the Sky with Diamonds’ Passes Away at 46It seems that every day, another bright light around the world is lost to lupus. On a...
Source: www.youtube.com
The worlds leading private supporter of innovative research in lupus, the Lupus Research Institute champions scientific risk-taking in the hunt for solutions to this complex and dangerous autoimmune disease.
"It's very frustrating because I know what my symptoms are," said Debby Schultz of Racine. It was the blue hands which pushed her toward an answer...
Lupus Research Institute LRI advocate Kate Kelly shares her Advocacy Day experience on the Huffington Post - a must read!
Source: www.huffingtonpost.com
If there are days when you step away from the news feeling discouraged about this country, I have a solution: Plan a trip to Washington, D.C. and spend a day on Capitol Hill. You will be reminded that ...
